Hypertensive Nephrosclerosis CKD Progression Risk

Estimate CKD progression risk in hypertensive nephrosclerosis based on blood pressure control, GFR, albuminuria, and comorbidities using KDIGO heat map categories.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Estimate CKD progression risk in hypertensive nephrosclerosis based on blood pressure control, GFR, albuminuria, and comorbidities using KDIGO heat map categories

Each component has a specific meaning:

  • Blood pressure control — The blood pressure control recorded for the scenario being assessed.
  • GFR — The gfr recorded for the scenario being assessed.
  • Albuminuria — The albuminuria recorded for the scenario being assessed.
  • Comorbidities — The comorbidities recorded for the scenario being assessed.

Note: Interpret the hypertensive nephrosclerosis result against the thresholds and context described above.

How to Use

Enter the blood pressure control, GFR, albuminuria, comorbidities for the scenario you are assessing. Estimate CKD progression risk in hypertensive nephrosclerosis based on blood pressure control, GFR, albuminuria, and comorbidities using KDIGO heat map categories. Use the hypertensive nephrosclerosis result to inform your calculation.

Frequently Asked Questions